Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. - Kapoor P; Fonseca R; Rajkumar SV; Sinha S; Gertz MA; Stewart AK; Bergsagel PL; Lacy MQ; Dingli DD; Ketterling RP; Buadi F; Kyle RA; et al. (Mayo Clinic Proceedings, 2010)